• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

AbbVie lifts profit target after cancer drug powers quarterly beat

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 02, 2018 at 09:42: AM
via AbbVie Inc (ABBV.N) beat Wall Street estimates for third-quarter profit on Friday, driven by strong sales of blockbuster cancer medicine Imbruvica, and the drugmaker raised its 2018 earnings forecast, sending its shares up 4 percent.

article source
 




Top Bottom
Back
Quote